Biotechnology
Investing News
Market News
FDA Refuses to Review Zogenix Drug to Treat Childhood Epilepsy
Shares of Zogenix, Inc. (NASDAQ: ZGNX) fell 30% on Monday after the U.S. Food and Drug Administration refused to review its treatment for seizures associated with a rare form...